Cancer Family
Malignant Neoplasm
CI-CAN-00000025CAExplore in graph →
20,116 active trials259 approved drugs3,741 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000025CAExplore in graph →
Clinical trials
90,685 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (11,163)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01086345 | Radiosurgery Plus Bevacizumab in Glioblastoma | terminated | Early Phase 1 | 9 | Case Comprehensive Cancer CenterOTHER | 1 | Jul 3, 2018 | clinicaltrials |
| NCT01724619 | Update and Biodistribution of [F-18]FMDHT pET/CT in Normal Healthy Volunteers and Patients With Metastatic Prostate Cancer - A First in Human Subject Study With [F-18] FMDHT | terminated | Early Phase 1 | 7 | Wake Forest University Health SciencesOTHER | 1 | Jul 3, 2018 |
| clinicaltrials |
| NCT01778933 | Intraoperative Imagery of Renal Nodules With Folate-fluorescein Conjugate(EC17) | completed | Early Phase 1 | 10 | University of PennsylvaniaOTHER | 1 | Jul 3, 2018 | clinicaltrials |
| NCT02971410 | Simvastatin in Overcoming Chemotherapy Resistance in Patients With Relapsed or Refractory Multiple Myeloma | withdrawn | Early Phase 1 | 0 | Wake Forest University Health SciencesOTHER | 1 | Jul 2, 2018 | clinicaltrials |
| NCT03559764 | Study of BCMA CAR-T in Multiple Myeloma | unknown | Early Phase 1 | 20 | Allife Medical Science and Technology Co., Ltd.INDUSTRY | 0 | Jun 18, 2018 | clinicaltrials |
| NCT01132014 | Autologous OC-DC Vaccine in Ovarian Cancer | completed | Early Phase 1 | 67 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Jun 11, 2018 | clinicaltrials |
| NCT02872519 | PET Imaging of Ovarian Carcinoma With 18F-FSPG | withdrawn | Early Phase 1 | 0 | Vanderbilt-Ingram Cancer CenterOTHER | 0 | Jun 6, 2018 | clinicaltrials |
| NCT03546478 | 99mTc Labelled Affibody SPECT/CT Imaging for Breast Cancer HER2 Characterization | completed | Early Phase 1 | 32 | Peking Union Medical College HospitalOTHER | 1 | Jun 6, 2018 | clinicaltrials |
| NCT01992718 | What Are we Missing? Diagnosing Uterine Adenomyosis Using Ultrasound Elastography | completed | Early Phase 1 | 49 | University of MichiganOTHER | 1 | May 31, 2018 | clinicaltrials |
| NCT01091792 | Exploratory Study of the Modulation of the Immune System by VEGF Blockade in Patients With Glioblastoma Multiforme (GBM) | completed | Early Phase 1 | 13 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | May 25, 2018 | clinicaltrials |
| NCT02012465 | Validation of Insulin Protocol for Glucocorticoid-induced Hyperglycemia in Diabetic Oncology Patients | completed | Early Phase 1 | 15 | Washington University School of MedicineOTHER | 1 | May 7, 2018 | clinicaltrials |
| NCT00890786 | A Study of Bevacizumab Therapy in Patients With Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine Gliomas | completed | Early Phase 1 | 27 | Children's Hospital Medical Center, CincinnatiOTHER | 1 | May 2, 2018 | clinicaltrials |
| NCT01962649 | A Pilot Study of Optical Molecular Imaging for Percutaneous Biopsy of Hepatocellular Carcinoma Using Indocyanine Green | completed | Early Phase 1 | 20 | Massachusetts General HospitalOTHER | 1 | Apr 25, 2018 | clinicaltrials |
| NCT02466828 | qBOLD MRI of Glioblastoma Multiforme for Assessment of Tumor Hypoxia. | completed | Early Phase 1 | 10 | Sunnybrook Health Sciences CentreOTHER | 1 | Apr 18, 2018 | clinicaltrials |
| NCT03497819 | Autologous CARTmeso/19 Against Pancreatic Cancer | unknown | Early Phase 1 | 10 | First Affiliated Hospital of Wenzhou Medical UniversityOTHER | 1 | Apr 13, 2018 | clinicaltrials |
| NCT03245554 | Clinical Research on Teratment of Gastrointestinal Cancer in the Preoperative by Propranolol | unknown | Early Phase 1 | 80 | Central South UniversityOTHER | 1 | Apr 9, 2018 | clinicaltrials |
| NCT01793948 | Metformin Hydrochloride vs. Placebo in Overweight or Obese Patients at Elevated Risk for Breast Cancer | completed | Early Phase 1 | 24 | Anna Maria StornioloOTHER | 1 | Mar 30, 2018 | clinicaltrials |
| NCT03235869 | Radiation Therapy Plus Durvalumab for Tumor-Stage Cutaneous T-Cell Lymphoma | withdrawn | Early Phase 1 | 0 | University of Michigan Rogel Cancer CenterOTHER | 1 | Mar 15, 2018 | clinicaltrials |
| NCT01933269 | FACBC for Head and Neck Cancers | withdrawn | Early Phase 1 | 0 | Emory UniversityOTHER | 0 | Feb 5, 2018 | clinicaltrials |
| NCT02608736 | Chemoprevention of Head and Neck Squamous Cell Carcinoma (HNSCC) With Valproic Acid(GAMA) | completed | Early Phase 1 | 42 | Barretos Cancer HospitalOTHER | 1 | Feb 1, 2018 | clinicaltrials |
| NCT02910804 | IRDye800CW-BBN PET-NIRF Imaging Guiding Surgery in Patients With Glioblastoma | unknown | Early Phase 1 | 30 | Beijing Tiantan HospitalOTHER | 1 | Jan 18, 2018 | clinicaltrials |
| NCT01261299 | Clinical Study of Microdosing Carboplatin in Lung or Bladder Cancer | terminated | Early Phase 1 | 21 | University of California, DavisOTHER | 1 | Jan 9, 2018 | clinicaltrials |
| NCT01568996 | Pilot Study Evaluating Sulforaphane in Atypical Nevi-Precursor Lesions | completed | Early Phase 1 | 17 | John KirkwoodOTHER | 1 | Jan 9, 2018 | clinicaltrials |
| NCT02077998 | Oxaliplatin in Treating Patients With Metastatic Breast Cancer | completed | Early Phase 1 | 1 | University of California, DavisOTHER | 1 | Jan 9, 2018 | clinicaltrials |
| NCT03385148 | The Clinical Application of 68Ga Labeled ssDNA Aptamer Sgc8 in Healthy Volunteers and Colorectal Patients | unknown | Early Phase 1 | 70 | Xijing HospitalOTHER | 1 | Dec 28, 2017 | clinicaltrials |
| NCT02463383 | Effect of PPARγ2 Polymorphism and NSAIDs on Acute Alcohol-induced Changes in Serum Estrogens Among Post-menopausal Women(EPPNASE) | completed | Early Phase 1 | 25 | Professor Lars Ove DragstedOTHER | 1 | Dec 12, 2017 | clinicaltrials |
| NCT01631331 | Vismodegib in Treating Patients With Basal Cell Carcinoma (BCC) | completed | Early Phase 1 | 15 | Stanford UniversityOTHER | 1 | Dec 8, 2017 | clinicaltrials |
| NCT00972933 | Immunogenicity and Biomarker Analysis of Neoadjuvant Ipilimumab for Melanoma | completed | Early Phase 1 | 59 | Diwakar DavarOTHER | 1 | Dec 7, 2017 | clinicaltrials |
| NCT01867593 | MET-PET for Newly Diagnosed Glioblastoma | completed | Early Phase 1 | 20 | Massachusetts General HospitalOTHER | 1 | Oct 13, 2017 | clinicaltrials |
| NCT00725946 | Pilot Study to Determine Radioiodide Accumulation and Dosimetry in Breast Cancers Using 124I PET/CT | terminated | Early Phase 1 | 7 | Stanford UniversityOTHER | 1 | Oct 11, 2017 | clinicaltrials |
| NCT03228303 | Nilotinib Versus Imatinib in Treatment of Patients With Newly Diagnosed Chronic Myeloid Leukemia | unknown | Early Phase 1 | 100 | Assiut UniversityOTHER | 0 | Oct 10, 2017 | clinicaltrials |
| NCT02691169 | Integrated 18F-labelled PSMA Project | unknown | Early Phase 1 | 10 | St. Joseph's Healthcare HamiltonOTHER | 1 | Oct 9, 2017 | clinicaltrials |
| NCT02774512 | Predictive Biomarkers of Biological Activity and Efficacy of Nilotinib on ZAK Target in Non-metastatic Colon Cancer(ZAK-0) | withdrawn | Early Phase 1 | 0 | Institut BergoniéOTHER | 1 | Oct 6, 2017 | clinicaltrials |
| NCT00965003 | MRI Laryngeal Imaging With a Surface Coil | terminated | Early Phase 1 | 3 | Stanford UniversityOTHER | 1 | Oct 5, 2017 | clinicaltrials |
| NCT03288298 | Therapeutic Effect Of Luteolin Natural Extract Versus Its Nanoparticles On Tongue Squamous Cell Carcinoma Cell Line | unknown | Early Phase 1 | 4 | Cairo UniversityOTHER | 0 | Sep 20, 2017 | clinicaltrials |
| NCT02490930 | A Safety Study of Fingolimod With Radiation and Temozolomide in Newly Diagnosed High Grade Glioma | completed | Early Phase 1 | 5 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Sep 13, 2017 | clinicaltrials |
| NCT01864083 | FACBC PET and PEM as a Staging Tool and Indicator of Therapeutic Response in Breast Cancer Patients | completed | Early Phase 1 | 30 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 31, 2017 | clinicaltrials |
| NCT02452216 | Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS | completed | Early Phase 1 | 10 | Michael IvOTHER | 1 | Aug 31, 2017 | clinicaltrials |
| NCT03267173 | Evaluate the Safety and Efficacy of CAR-T in the Treatment of Pancreatic Cancer. | unknown | Early Phase 1 | 10 | First Affiliated Hospital of Harbin Medical UniversityOTHER | 1 | Aug 30, 2017 | clinicaltrials |
| NCT00395109 | PET/CT to Image Hypoxia in Head and Neck Tumours | completed | Early Phase 1 | 17 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Aug 28, 2017 | clinicaltrials |
| NCT01247298 | A Pilot Study of Trans Arterial Chemoembolization (TACE), Followed by Stereotactic Radiation Therapy (SBRT) for Patients With Hepatocellular Carcinoma(RAD 0902) | completed | Early Phase 1 | 17 | University of Alabama at BirminghamOTHER | 1 | Aug 21, 2017 | clinicaltrials |
| NCT00871533 | Pilot Study of IFN α2b for Melanoma Patients | terminated | Early Phase 1 | 50 | University of PittsburghOTHER | 1 | Aug 4, 2017 | clinicaltrials |
| NCT03070613 | Investigating the Use of Fluorescent Lectins to Identify Dysplasia and Cancer During Endoscopy and Surgery | unknown | Early Phase 1 | 50 | University of OxfordOTHER | 1 | Jul 18, 2017 | clinicaltrials |
| NCT03214939 | Autologous Antigen-activated Dendritic Cells in the Treatment of Patients With Colorectal Cancer | unknown | Early Phase 1 | 30 | Research Institute of Fundamental and Clinical ImmunologyOTHER_GOV | 1 | Jul 12, 2017 | clinicaltrials |
| NCT01632696 | Open-label, Single Arm, Tumor Imaging and Dosimetry Study of I-124 PGN650 in Advanced Solid Tumors | terminated | Early Phase 1 | 11 | Peregrine PharmaceuticalsINDUSTRY | 1 | Jul 11, 2017 | clinicaltrials |
| NCT00020670 | Vaccine Therapy in Treating Patients With Acute Lymphoblastic Leukemia | terminated | Early Phase 1 | 9 | Dana-Farber Cancer InstituteOTHER | 1 | Jun 20, 2017 | clinicaltrials |
| NCT02593929 | Pharmacodynamic Effects and Predictive Biomarkers With Ruxolitinib in Operable Head and Neck Cancer | withdrawn | Early Phase 1 | 0 | University of PittsburghOTHER | 0 | Jun 8, 2017 | clinicaltrials |
| NCT01205672 | Evaluation of the Molecular Effects of Metformin on the Endometrium in Patients With Endometrial Cancer | completed | Early Phase 1 | 21 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 2, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Jul 3, 2018source: clinicaltrials